RESOLVE™
A new category for cancer detection
Cancer is not a single moment. It is a process that unfolds over time. RESOLVE introduces a new category of solutions designed to bring clarity when cancer is a concern — bridging the space between suspicion of cancer and diagnosis, replacing uncertainty with resolution.

What IS RESOLVE?
A new category in
cancer care
RESOLVE is a category-defining set of solutions from Harbinger Health focused on resolving cancer-related uncertainty. Built on a biology-first understanding of cancer emergence, RESOLVE addresses moments in care where traditional tools leave clinicians and patients without clear direction.

THE SCIENCE
Harbinger uses a developmental biology lens to identify the earliest reactivation of core biological programs that initiate oncogenesis. These programs emerge before many conventional molecular changes are detectable and provide a window into the beginnings of cancer, not just its consequences.
Platform & Technology
The engine behind RESOLVE™
Harbinger HX is the integrated platform that powers the RESOLVE™ category of solutions. It brings together biology, technology, data, and analytics into a modular system that can be adapted to address a wide range of clinical questions.
HX is built to scale—supporting today’s RESOLVE™ solutions while enabling future applications across cancers and clinical contexts.
Partnerships
Built to integrate. Designed to expand what’s possible.
Whether integrating RESOLVE™ solutions or leveraging the HX platform to accelerate innovation, our partnerships are grounded in shared scientific rigor and practical impact.
Current partners:
News & Insights
Latest news, Perspectives & Publications
